Double-Blind Study of Miglitol in Japanese With type2 Diabetes

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

To investigate the efficacy and safety of miglitol in Japanese patients with type 2 diabetes that is insufficiently controlled diet alone.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd.
• Treatments: Miglitol

Criteria

Inclusion Criteria:

• Type2 diabetic patient on Dietary Therapy

• Criteria for postprandial plasma glucose and HbA1c are met

Exclusion Criteria:

• Type1 diabetes

• Patients treated with antidiabetic drugs or Insulin